BlackRock Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.02M | Sell |
31,071
-48,143
| -61% | -$1.58M | ﹤0.01% | 1797 |
|
|
2016
Q3 | $2.5M | Sell |
79,214
-2,411
| -3% | -$76K | ﹤0.01% | 1333 |
|
|
2016
Q2 | $2.3M | Buy |
81,625
+16,853
| +26% | +$474K | ﹤0.01% | 1350 |
|
|
2016
Q1 | $2.35M | Buy |
64,772
+2,316
| +4% | +$84.2K | ﹤0.01% | 1322 |
|
|
2015
Q4 | $2.5M | Sell |
62,456
-14,105
| -18% | -$564K | ﹤0.01% | 1303 |
|
|
2015
Q3 | $2.18M | Buy |
76,561
+5,935
| +8% | +$169K | ﹤0.01% | 1314 |
|
|
2015
Q2 | $2.33M | Sell |
70,626
-25,647
| -27% | -$845K | ﹤0.01% | 1169 |
|
|
2015
Q1 | $2.77M | Buy |
96,273
+1,136
| +1% | +$32.7K | ﹤0.01% | 1080 |
|
|
2014
Q4 | $2.59M | Sell |
95,137
-15,550
| -14% | -$423K | ﹤0.01% | 1107 |
|
|
2014
Q3 | $2.36M | Sell |
110,687
-7,403
| -6% | -$158K | ﹤0.01% | 1106 |
|
|
2014
Q2 | $2.65M | Buy |
118,090
+6,252
| +6% | +$140K | ﹤0.01% | 1076 |
|
|
2014
Q1 | $2.83M | Sell |
111,838
-188,152
| -63% | -$4.75M | ﹤0.01% | 1076 |
|
|
2013
Q4 | $6.9M | Buy |
299,990
+211,553
| +239% | +$4.86M | 0.01% | 897 |
|
|
2013
Q3 | $1.69M | Buy |
88,437
+71,124
| +411% | +$1.36M | ﹤0.01% | 1198 |
|
|
2013
Q2 | $250K | Buy |
+17,313
| New | +$250K | ﹤0.01% | 2333 |
|